Iron Sucrose In The Treatment of Restless Legs Syndrome (RLS): The Safety of Three Dose Regimens as Evaluated by Clinical Assessments

This study has been completed.

Sponsor:

Information provided by:

Luitpold Pharmaceuticals

ClinicalTrials.gov Identifier:

NCT00895232

First received: May 7, 2009

Last updated: NA

Last verified: May 2009

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	August 2005 (Final data collection date for primary outcome measure)